Neonatal immune stimulation results in sex‐specific changes in ultrasonic vocalizations but does not affect seizure susceptibility in neonatal mice
Danielle Santana‐Coelho,Zachary J. Pranske,Suzanne O. Nolan,Samantha L. Hodges,Matthew S. Binder,Paige D. Womble,David A. Narvaiz,Ilyasah Muhammad,Joaquin N. Lugo
DOI: https://doi.org/10.1002/jdn.10333
2024-05-09
International Journal of Developmental Neuroscience
Abstract:Pups were treated with 0.1 mg/kg lipopolysaccharide (LPS) at postnatal day 10. Isolation‐induced ultrasonic vocalizations were recorded on postnatal day 12. LPS treatment induced sex‐dependent alterations in the total number of calls performed by the pups and the vocal repertoire. Seizure latency was assessed at 4 hrs, 2 days (PD12), or 5 days (PD15) after LPS treatment. LPS did not affect seizure latency at any of the time points measured in the study. Neuroinflammation during the neonatal period has been linked to disorders such as autism and epilepsy. In this study, we investigated the early life behavioral consequences of a single injection of lipopolysaccharide (LPS) at postnatal day 10 (PD10) in mice. To assess deficits in communication, we performed the isolation‐induced ultrasonic vocalizations (USVs) test at PD12. To determine if early life immune stimulus could alter seizure susceptibility, latency to flurothyl‐induced generalized seizures was measured at 4 hours (hrs), 2 days, or 5 days after LPS injections. LPS had a sex‐dependent effect on USV number. LPS‐treated male mice presented significantly fewer USVs than LPS‐treated female mice. However, the number of calls did not significantly differ between control and LPS for either sex. In male mice, we found that downward, short, and composite calls were significantly more prevalent in the LPS treatment group, while upward, chevron, and complex calls were less prevalent than in controls (p
neurosciences,developmental biology